Next Article in Journal
Subcutaneous Infliximab [CT-P13], a True Biologic 2.0. Real Clinical Practice Multicentre Study
Next Article in Special Issue
Time-Updated Phenotypic Guidance of Corticosteroids and Antibiotics in COPD: Rationale, Perspective and a Proposed Method
Previous Article in Journal
Clinical Application of Pharmacokinetics to Appraise Adherence to Levetiracetam in Portuguese Epileptic Patients
Previous Article in Special Issue
Biomarkers of Clot Activation and Degradation and Risk of Future Major Cardiovascular Events in Acute Exacerbation of COPD: A Cohort Sub-Study in a Randomized Trial Population
 
 
Review

Article Versions Notes

Biomedicines 2022, 10(9), 2128; https://doi.org/10.3390/biomedicines10092128
Action Date Notes Link
article pdf uploaded. 30 August 2022 16:11 CEST Version of Record https://www.mdpi.com/2227-9059/10/9/2128/pdf-vor
article xml file uploaded 1 September 2022 07:47 CEST Original file -
article xml uploaded. 1 September 2022 07:47 CEST Update https://www.mdpi.com/2227-9059/10/9/2128/xml
article pdf uploaded. 1 September 2022 07:47 CEST Updated version of record https://www.mdpi.com/2227-9059/10/9/2128/pdf
article html file updated 1 September 2022 07:48 CEST Original file -
article html file updated 28 February 2023 11:34 CET Update https://www.mdpi.com/2227-9059/10/9/2128/html
Back to TopTop